Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
SPARC.NSthis companySun Pharma Advanced Research Company Limited	₹210.80	2.4×	2.78×	1.98×	2.68×	-990.7%	91.9%	84.5%	82.7%	116.0%	80.4%	-8.0%	0.42×	0.35×	46.54×	2.47×	0.0%	4	—	2	C+
ASTRAZEN.NSAstraZeneca Pharma India Limited	₹6,529.00	103.53×	22.24×	8.53×	66.87×	74.4%	26.5%	10.3%	8.2%	21.5%	17.0%	0.0%	0.13×	-1.18×	51.99×	1.77×	0.4%	3	—	2	C+
AUROPHARMA.NSAurobindo Pharma Limited	₹1,855.30	21.62×	2×	2.25×	10.17×	130.3%	39.2%	15.1%	10.4%	9.2%	7.3%	3.7%	0.21×	-0.25×	13.22×	1.81×	0.3%	5	—	2	B-
CIPLA.NSCipla Limited	₹1,403.80	25.49×	2.87×	3.51×	15.19×	112.4%	42.7%	16.7%	13.8%	11.3%	9.8%	2.6%	0.02×	-0.06×	86.67×	3.44×	1.3%	4	9.92	4	A-
CONCORDBIO.NSConcord Biotech Limited	₹596.80	41.1×	5.32×	10.16×	25.54×	-74.8%	41.9%	27.8%	24.7%	12.9%	10.7%	1.6%	0×	-0.03×	1,034.4×	7.39×	1.0%	3	30.82	3	B+
DRREDDY.NSDr. Reddy's Laboratories Limited	₹1,385.00	24.38×	2.77×	3.11×	14.13×	25.1%	52.8%	13.8%	12.8%	11.4%	7.5%	2.9%	0.24×	0.94×	12.42×	1.8×	0.6%	7	5.66	3	B+
Peer median	—	25.49×	2.87×	3.51×	15.19×	74.4%	41.9%	15.1%	12.8%	11.4%	9.8%	2.6%	0.13×	-0.06×	51.99×	1.81×	0.6%	4	9.92	3	—